Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-14 · accession 0002014866-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-17 | 2026-03-14 | INDV | Preblick Ryan | CFO | F - Tax | $31.11 | -2,843 | 320.8K | -0.9% | -$88.4K |
| D | 2026-03-17 | 2026-03-14 | INDV | Preblick Ryan | CFO | M - OptEx | — | +6,302 | 323.6K | +2% | — |
| D | 2026-03-17 | 2026-03-14 | INDV | Preblick Ryan | CFO | M - OptEx | — | -6,302 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-14 | F | D | 2,843 | $31.11 | 320,751 | D | — | — | (F2) Shares used to satisfy tax withholding obligations associated with the vesting of RSUs on March 14, 2026. |
| 2 | Common | Common Stock | 2026-03-14 | M | A | 6,302 | — | 323,594 | D | — | — | (F1) Restricted stock units (RSUs) convert into shares of the Issuer's common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2026-03-14 | M | D | 6,302 | — | 0 | D | $0.00 · 2026-03-14 to — | 6,302 Common Stock | (F1) Restricted stock units (RSUs) convert into shares of the Issuer's common stock on a one-for-one basis. (F3) On March 14, 2024, the reporting person was granted 6,302 RSUs in accordance with the Indivior Group Deferred Bonus Plan 2018. Those RSUs vested in a single installment on March 14, 2026. |